Validation of Multi-epitope Peptides Encapsulated in PLGA Nanoparticles Against Influenza A Virus

No abstract is available for this paper.

• Publication year

  2023

• Venue

  Pharmaceutical Research

• Publication date

  2023-06-21

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/s11095-023-03540-xPMID 37344603
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• T cell apoptosis characterizes severe Covid-19 disease

  2022cited by this paper
• Safety and immunogenicity of a ferritin nanoparticle H2 influenza vaccine in healthy adults: a phase 1 trial

  2022cited by this paper
• Advances in Infectious Disease Vaccine Adjuvants

  2022cited by this paper
• CpG-Containing Oligodeoxynucleotides and Freund Adjuvant in Combination with Alum Augment the Production of Monoclonal Antibodies Against Recombinant HBsAg

  2022cited by this paper
• In silico epitope-based vaccine design against influenza a neuraminidase protein: Computational analysis established on B- and T-cell epitope predictions

  2022cited by this paper
• Influenza and Influenza Vaccine: A Review

  2021cited by this paper
• Revealing macropinocytosis using nanoparticles.

  2021cited by this paper
• Adjuvantation of Influenza Vaccines to Induce Cross-Protective Immunity

  2021cited by this paper
• Serum IgG anti-SARS-CoV-2 Binding Antibody Level Is Strongly Associated With IgA and Functional Antibody Levels in Adults Infected With SARS-CoV-2

  2021cited by this paper
• Immunoinformatics approach for a novel multi-epitope subunit vaccine design against various subtypes of Influenza A virus.

  2021cited by this paper
• PLGA Based Nanospheres as a Potent Macrophage-Specific Drug Delivery System

  2021cited by this paper
• Safety and Immunogenicity of a Novel Intranasal Influenza Vaccine (NasoVAX): A Phase 2 Randomized, Controlled Trial

  2021cited by this paper
• Decline in Seasonal Influenza Vaccine Effectiveness With Vaccination Program Maturation: A Systematic Review and Meta-analysis

  2021cited by this paper
• A Multiepitope Peptide, rOmp22, Encapsulated in Chitosan-PLGA Nanoparticles as a Candidate Vaccine Against Acinetobacter baumannii Infection

  2021cited by this paper
• A panel of anti-influenza virus nucleoprotein antibodies selected from phage-displayed synthetic antibody libraries with rapid diagnostic capability to distinguish diverse influenza virus subtypes

  2020cited by this paper
• Adjuvantation of an Influenza Hemagglutinin Antigen with TLR4 and NOD2 Agonists Encapsulated in Poly(D,L-Lactide-Co-Glycolide) Nanoparticles Enhances Immunogenicity and Protection against Lethal Influenza Virus Infection in Mice

  2020cited by this paper
• Designing Multi-Epitope Vaccines to Combat Emerging Coronavirus Disease 2019 (COVID-19) by Employing Immuno-Informatics Approach

  2020cited by this paper
• Impaired immune cell cytotoxicity in severe COVID-19 is IL-6 dependent.

  2020cited by this paper
• Elevated exhaustion levels and reduced functional diversity of T cells in peripheral blood may predict severe progression in COVID-19 patients

  2020cited by this paper
• Seasonal and pandemic influenza: 100 years of progress, still much to learn

  2020cited by this paper
• Synthetic mycobacterial molecular patterns partially complete Freund’s adjuvant

  2020cited by this paper
• Efficient and prolonged antibacterial activity from porous PLGA microparticles and their application in food preservation.

  2020cited by this paper
• Glycan repositioning of influenza hemagglutinin stem facilitates the elicitation of protective cross-group antibody responses

  2020cited by this paper
• Next-generation influenza vaccines: opportunities and challenges

  2020cited by this paper
• Interim Estimates of 2019–20 Seasonal Influenza Vaccine Effectiveness — United States, February 2020

  2020cited by this paper
• Immunogenicity, Safety, and Efficacy of a Standalone Universal Influenza Vaccine, FLU-v, in Healthy Adults

  2020cited by this paper
• A conserved multi-epitope-based vaccine designed by targeting hemagglutinin protein of highly pathogenic avian H5 influenza viruses

  2020cited by this paper
• Phenomenology of the Initial Burst Release of Drugs from PLGA Microparticles.

  2020cited by this paper
• Development and Optimization of In-house ELISA for Detection of Human IgG Antibody to SARS-CoV-2 Full Length Spike Protein

  2020cited by this paper
• New Generation Peptide-Based Vaccine Prototype

  2019cited by this paper
• CD4+ T help promotes influenza virus-specific CD8+ T cell memory by limiting metabolic dysfunction

  2019cited by this paper
• Vaccination with synthetic long peptide formulated with CpG in an oil-in-water emulsion induces robust E7-specific CD8 T cell responses and TC-1 tumor eradication

  2019cited by this paper
• Highly conserved influenza T cell epitopes induce broadly protective immunity.

  2019cited by this paper
• Epitope Prediction by Novel Immunoinformatics Approach: A State-of-the-art Review

  2019cited by this paper
• Polyethylenimine-coated PLGA nanoparticles-encapsulated Angelica sinensis polysaccharide as an adjuvant to enhance immune responses.

  2019cited by this paper
• Human CD8+ T cell cross-reactivity across influenza A, B and C viruses

  2019cited by this paper
• Peptide-Based Vaccines: Current Progress and Future Challenges

  2019cited by this paper
• Modified Vaccinia Ankara–Vectored Vaccine Expressing Nucleoprotein and Matrix Protein 1 (M1) Activates Mucosal M1-Specific T-Cell Immunity and Tissue-Resident Memory T Cells in Human Nasopharynx-Associated Lymphoid Tissue

  2019cited by this paper
• Application of built-in adjuvants for epitope-based vaccines

  2019cited by this paper
• PLGA encapsulated inactivated-viral vaccine: Formulation and evaluation of its protective efficacy against viral haemorrhagic septicaemia virus (VHSV) infection in olive flounder (Paralichthys olivaceus) vaccinated by mucosal delivery routes.

  2019cited by this paper
• Nanoparticle-Based Vaccines Against Respiratory Viruses

  2019cited by this paper
• Impact of Particle Size and Polydispersity Index on the Clinical Applications of Lipidic Nanocarrier Systems

  2018cited by this paper
• Harnessing the Power of T Cells: The Promising Hope for a Universal Influenza Vaccine

  2018cited by this paper
• Advancing Freund's and AddaVax Adjuvant Regimens Using CpG Oligodeoxynucleotides

  2018cited by this paper
• Class-B CpG-ODN Formulated With a Nanostructure Induces Type I Interferons-Dependent and CD4+ T Cell-Independent CD8+ T-Cell Response Against Unconjugated Protein Antigen

  2018cited by this paper
• Vaccination potential of B and T epitope-enriched NP and M2 against Influenza A viruses from different clades and hosts

  2018cited by this paper
• CpG ODN1826 as a Promising Mucin1-Maltose-Binding Protein Vaccine Adjuvant Induced DC Maturation and Enhanced Antitumor Immunity

  2018cited by this paper
• Adjuvanted influenza vaccines

  2018cited by this paper
• A novel peptide-based vaccine candidate with protective efficacy against influenza A in a mouse model.

  2018cited by this paper
• Heterosubtypic influenza protection elicited by double-layered polypeptide nanoparticles in mice

  2018cited by this paper
• Estimates of global seasonal influenza-associated respiratory mortality: a modelling study.

  2017cited by this paper
• M2e-tetramer-specific memory CD4 T cells are broadly protective against influenza infection

  2017cited by this paper
• Human Scavenger Receptor A1-Mediated Inflammatory Response to Silica Particle Exposure Is Size Specific

  2017cited by this paper
• Epitope specific T‐cell responses against influenza A in a healthy population

  2016cited by this paper
• PLGA particulate delivery systems for subunit vaccines : Linking particle properties to immunogenicity

  2016cited by this paper
• Identification of a CD4 T-cell epitope in the hemagglutinin stalk domain of pandemic H1N1 influenza virus and its antigen-driven TCR usage signature in BALB/c mice

  2016cited by this paper
• PLGA particulate delivery systems for subunit vaccines: Linking particle properties to immunogenicity

  2016cited by this paper
• Heterosubtypic T-Cell Immunity to Influenza in Humans: Challenges for Universal T-Cell Influenza Vaccines

  2016cited by this paper
• Topical CpG Oligodeoxynucleotide Adjuvant Enhances the Adaptive Immune Response against Influenza A Infections

  2016cited by this paper
• Entrapment of H1N1 Influenza Virus Derived Conserved Peptides in PLGA Nanoparticles Enhances T Cell Response and Vaccine Efficacy in Pigs

  2016cited by this paper
• Peptide/protein vaccine delivery system based on PLGA particles

  2016cited by this paper
• Synthetic Long Peptide Influenza Vaccine Containing Conserved T and B Cell Epitopes Reduces Viral Load in Lungs of Mice and Ferrets

  2015cited by this paper
• Formulation and evaluation of PLGA nanoparticles loaded capecitabine for prostate cancer.

  2015cited by this paper
• Improving Multi-Epitope Long Peptide Vaccine Potency by Using a Strategy that Enhances CD4+ T Help in BALB/c Mice

  2015cited by this paper
• Novel PLGA-based nanoparticles for the oral delivery of insulin

  2015cited by this paper
• Protection against Multiple Influenza A Virus Strains Induced by Candidate Recombinant Vaccine Based on Heterologous M2e Peptides Linked to Flagellin

  2015cited by this paper
• Recent progress in adjuvant discovery for peptide-based subunit vaccines

  2014cited by this paper
• Different endocytotic uptake mechanisms for nanoparticles in epithelial cells and macrophages

  2014cited by this paper
• The Immunodominant Influenza A Virus M158–66 Cytotoxic T Lymphocyte Epitope Exhibits Degenerate Class I Major Histocompatibility Complex Restriction in Humans

  2014cited by this paper
• Schistosome Vaccine Adjuvants in Preclinical and Clinical Research

  2014cited by this paper
• An M2e-based synthetic peptide vaccine for influenza A virus confers heterosubtypic protection from lethal virus challenge

  2013cited by this paper
• Cellular immune correlates of protection against symptomatic pandemic influenza

  2013cited by this paper
• Advances in the study of HLA-restricted epitope vaccines

  2013cited by this paper
• Clinical Assessment of a Novel Recombinant Simian Adenovirus ChAdOx1 as a Vectored Vaccine Expressing Conserved Influenza A Antigens

  2013cited by this paper
• Preexisting influenza-specific CD4+ T cells correlate with disease protection against influenza challenge in humans

  2012cited by this paper
• Targeting malignant mitochondria with therapeutic peptides.

  2012cited by this paper
• Safety and Immunogenicity of Multimeric-001—a Novel Universal Influenza Vaccine

  2012cited by this paper
• Engineering of blended nanoparticle platform for delivery of mitochondria-acting therapeutics

  2012cited by this paper
• Understanding the immune response to seasonal influenza vaccination in older adults: a systems biology approach

  2012cited by this paper
• Physicochemical characterization and in vitro hemolysis evaluation of silver nanoparticles.

  2011cited by this paper
• The uptake of PLGA micro or nanoparticles by macrophages provokes distinct in vitro inflammatory response.

  2011cited by this paper
• Conserved epitopes of influenza A virus inducing protective immunity and their prospects for universal vaccine development

  2010cited by this paper
• In vivo evaluation of the biodistribution and safety of PLGA nanoparticles as drug delivery systems.

  2010cited by this paper
• Vaccination with a synthetic peptide from the influenza virus hemagglutinin provides protection against distinct viral subtypes

  2010cited by this paper
• The co-administration of CpG-ODN influenced protective activity of influenza M2e vaccine.

  2009cited by this paper
• Baseline mechanical characterization of J774 macrophages.

  2009cited by this paper
• Immunomic Analysis of the Repertoire of T-Cell Specificities for Influenza A Virus in Humans

  2008influential reference
• BMC Bioinformatics BioMed Central Methodology article VaxiJen: a server for prediction of protective antigens, tumour

  2007cited by this paper
• Enhanced and prolonged cross‐presentation following endosomal escape of exogenous antigens encapsulated in biodegradable nanoparticles

  2006cited by this paper
• Prediction of continuous B‐cell epitopes in an antigen using recurrent neural network

  2006cited by this paper
• Innate immunity mediated by epidermal keratinocytes promotes acquired immunity involving Langerhans cells and T cells in the skin

  2006cited by this paper
• CpG-Containing Oligodeoxynucleotides Act through TLR9 to Enhance the NK Cell Cytokine Response to Antibody-Coated Tumor Cells 1

  2005cited by this paper
• CpG DNA as a vaccine adjuvant

  2003cited by this paper
• Characterization of the initial burst release of a model peptide from poly(D,L-lactide-co-glycolide) microspheres.

  2002cited by this paper
• Adjuvant activity of incomplete Freund's adjuvant.

  1998cited by this paper
• International Journal of Nanomedicine Dovepress Suitable Carriers for Encapsulation and Distribution of Endostar: Comparison of Endostar-loaded Particulate Carriers

  year unknowncited by this paper

• Nanoparticles in influenza research: a bibliometric analysis of global trends (2005 - 2025)

  2026cites this paper
• Recent Advances in Peptide-Loaded PLGA Nanocarriers for Drug Delivery and Regenerative Medicine

  2025cites this paper
• In vitro characterization of the E. ruminantium pLAMP multi-epitope DNA poly (lactic-co-glycolic acid) nanoparticle vaccine in sheep peripheral blood mononuclear cells.

  2025cites this paper
• Structural modification strategies for ferritin nanoparticles and their applications in biomedicine: a narrative review.

  2025cites this paper
• Nanovaccines: Innovative Advances from Design Strategies to Clinical Translation

  2025cites this paper
• Research Progress of Universal Influenza Vaccine

  2025cites this paper
• Reactive oxygen species-responsive virus-mimicking nanodrug for the treatment of influenza A virus infection.

  2025cites this paper
• Brief Comparison of Novel Influenza Vaccine Design Strategies

  2025cites this paper
• Recent Advances in Peptide Drug Discovery: Novel Strategies and Targeted Protein Degradation

  2024cites this paper
• The quest for nanoparticle-powered vaccines in cancer immunotherapy

  2024cites this paper
• Bioinformatic, Biochemical, and Immunological Mining of MHC Class I Restricted T Cell Epitopes for a Marburg Nucleoprotein Microparticle Vaccine

  2024cites this paper
• Influenza Virus-Derived CD8 T Cell Epitopes: Implications for the Development of Universal Influenza Vaccines

  2024cites this paper
• Immunogenicity of trivalent DNA vaccine candidate encapsulated in Chitosan-TPP nanoparticles against EV-A71 and CV-A16.

  2024cites this paper
• Optimization and evaluation of a chitosan-coated PLGA nanocarrier for mucosal delivery of Porphyromonas gingivalis antigens.

  2024cites this paper
• RABV antigenic peptide loaded polymeric nanoparticle production, characterization, and preliminary investigation of its biological activity

  2024cites this paper
• Therapeutic Targeting of MOAP-1 in Cancer: A Systematic Review of Current Approaches and Future Directions

  2023cites this paper